- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Immune Pharmaceuticals Inc+ Add to Watchlist
IMNP:US1.7900 USD 0.6600 26.94%
As of 20:10:00 ET on 12/10/2013.
Company Profile for Immune Pharmaceuticals Inc (IMNP)
Immune Pharmaceuticals Inc. is a biopharmaceutical company. The Company focuses on the development of antibody therapeutics to address medical needs in the treatment of inflammatory diseases and cancer.
Immune Pharmaceuticals Inc
Key Executives for Immune Pharmaceuticals Inc (IMNP)
|Daniel Geodeon TeperChairman/CEO||Stephane AllardChief Medical Officer|
|Robert W CookSenior VP/CFO||Anna BaranDir:Investor Relations|